Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
Clinical trial NCT01234025 · COMPLETED
Trial details
- NCT number
- NCT01234025
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-05-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.